The world's first Parkinson's vaccine trial
The world's first Parkinson's vaccine has been tested in humans, according to New Scientist .
It is known that in this first trial, 10 patients with Parkinson's disease were vaccinated against Parkinson's disease to fight the disease.
The vaccine is called PD01A , a drug that boosts the immune system to destroy alpha-synuclein, a protein that is thought to cause Parkinson's disease.
Protein is accumulated in the brain, disrupting the production of dopamine, destroying nerve cells and their association, according to Mandler Markus, an expert at Affiris, the company that developed the vaccine.
Most current treatments only reduce symptoms of the disease by increasing dopamine levels.
In total, 32 people will be vaccinated during their first human test. The purpose of the experiment is to ensure safe vaccination. Researchers will also monitor for signs of the development of symptoms if any.
- Harvard's HIV vaccine was initially successful on humans
- The trial of malaria vaccine achieved positive results
- Launch of HIV vaccine trial in Africa
- Trial of malaria vaccine failed
- The first vaccine against malaria loses its effectiveness after 4 years of injection
- Russia has a clinical trial of three vaccines that protect against HIV
- The United States accelerates testing of Ebola vaccine in humans
- Russia successfully tested the vaccine - asking for HIV
- Cuba expands clinical trial of vaccine against prostate cancer
- Conduct a trial on human malaria vaccine
- Poor countries have limited access to H1N1 flu vaccine
- Novartis began testing the A / H1N1 flu vaccine